CIK 0001707502
- Non-accelerated filer
- Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900943402
- Phone
- +1 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +787,586 | $5.53 | $4.4M | 787,586 |
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +663,720 | $5.53 | $3.7M | 11,580,287 |
| 2021-03-23 | Koppel Adam Director | Grant or award | +869,565 | $5.75 | $5.0M | 7,929,918 |
| 2021-03-23 | PERCEPTIVE ADVISORS LLC Director | Purchase | +2,608,695 | $5.75 | $15.0M | 13,412,552 |
| 2021-03-19 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,206,685 | $5.75 | $12.7M | 10,916,567 |
| 2021-03-12 | Morris Carl Ashley Chief Scientific Officer | Sale | −11,699 | $8.84 | $103K | 287,301 |
| 2021-03-12 | Morris Carl Ashley Chief Scientific Officer | Sale | −11,699 | $8.85 | $103K | 275,602 |
| 2021-03-12 | Schneider Joel Solomon Zev Chief Operating Officer | Sale | −11,699 | $8.84 | $103K | 280,473 |
| 2021-03-12 | Schneider Joel Solomon Zev Chief Operating Officer | Sale | −11,699 | $8.84 | $103K | 268,774 |
| 2021-03-02 | Keresty Georgia Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-02 | Kahn Clare Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-03-02 | Schneider Joel Solomon Zev Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-01 | Brennan Erin Powers Chief Legal Officer, Secretary | Grant or award · Employee Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2021-02-12 | Ganot Ilan CEO & President | Sale | −457 | $7.66 | $4K | 3,026 |
| 2021-01-28 | Schneider Joel Solomon Zev Chief Technology Officer | Sale | −3,443 | $6.14 | $21K | 292,172 |
| 2021-01-28 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Sale | −3,473 | $6.14 | $21K | 335,636 |
| 2021-01-28 | Morris Carl Ashley Chief Scientific Officer | Sale | −3,459 | $6.14 | $21K | 299,000 |
| 2021-01-28 | Ganot Ilan CEO & President | Sale | −10,713 | $6.14 | $66K | 1,199,821 |
| 2021-01-27 | Schneider Joel Solomon Zev Chief Technology Officer | Exercise or conversion | +11,500 | 295,615 | ||
| 2021-01-27 | Schneider Joel Solomon Zev Chief Technology Officer | Exercise or conversion · Restricted Stock Units | −11,500 | 0 |
Page 22 of 31 · 604 trades